1,2-Benzothiazine Derivatives as Anti-HIV and Anti-HCV Agents: Structure–Activity Relationships and Research Perspectives
Izabela Topolska, Berenika M. Szczęśniak-Sięga · 2026
Read 1,2-Benzothiazine Derivatives as Anti-HIV and Anti-HCV Agents: Structure–Activity Relationships and Research Perspectives by Izabela Topolska, Berenika M. Szczęśniak-Sięga (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13565988.txt.
Description
Izabela Topolska and Berenika Szczesniak-Siega review a family of compounds against two viruses in 2026. The compounds share a sulfur-bearing ring that can be varied in many ways. Changing two key spots on the ring shifts how well they fight HIV and hepatitis C.
The review gathers published tests and maps which changes help or hurt. The best HIV compound worked at a low dose in human blood cells. The best hepatitis C compound blocked a virus copying enzyme at a low dose. All compounds were still far weaker than standard drugs, so more tuning is needed.
Catalog record
| CREATOR | Izabela Topolska, Berenika M. Szczęśniak-Sięga |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |